Share on Pinterest
Share with your friends


Richard Meyer

What do patients want?

ListenKEY TAKEAWAY: There are two things that today’s patients’ want in health care; empathy and to be heard.  Pharma has to find a way to take a more empathetic approach to DTC marketing if we want our efforts to be effective. Continue reading »

Effective patient relationship management

KEY TAKEAWAY: Effective patient relationship management can be very effective in both recruiting new patients and compliance, but in order for it to really provide a good ROI you have to think of patient segments, a lot of patient segments. Continue reading »

We have to be the change we want to see

UnknownKEY TAKEAWAY: If DTC marketing is to evolve and help patients make informed and educated healthcare decisions the industry needs people who both have the courage and the drive to implement changes.  We have to get away from “the same old business” of marketing. Continue reading »

What’s the point of pharma conferences?

waste_timeKEY TAKEAWAY: Pharma conferences are not meant to “improve marketing, rather they are a forum for marketers to share their marginal accomplishments.  Over the course of the year there are a lot of pharma conferences that focus on marketing yet pharma marketing still is stuck in the past. Continue reading »

Cheap money leads to pharma M&A

one dollaKEY TAKEAWAY: GlaxoSmithKline’s chief executive has warned that cheap money has increased the risk of companies making “poor choices” in mergers and acquisitions and questioned the “stretched” valuations of recent pharmaceuticals deals.  More than $460bn of deals have been struck across the pharma and biotech sectors since the start of last year — the busiest period of M&A on record.  So what effect is this going to have on DTC marketing and drug marketing in general?  Cuts and more cuts. Continue reading »

Pharma and social media: A qualitative look

analysis social mediaKEY TAKEAWAY: Analysis of two social media accounts, Twitter and Pinterest, show that the majority of followers were either industry people (media, agencies) and that patent followers were not engaging with the pharma brand. However levels of engagement vary by condition. Continue reading »

Patients get caught in the middle of pricing

UnknowninsurerKEY TAKEAWAY: DTC marketing is meant to drive new Rx’s but insurers are having a bigger say about which drugs patients get.  Can the drug industry make peace with insurers or is it going to be a battle of war between profits, Wall Street and patients. Continue reading »